PharmaShots | Incisive News in 3 Shots

Subscribe Now

dong-a st

Dong-A ST Receives EC Approval for Imuldosa (Biosimilar, Stelara)

Dong-A ST Receives EC Approval for Imuldosa (Biosimilar, Stelara)

December 20, 2024

Dong-A ST Receives the CHMP’s Positive Opinion for Imuldosa (Biosimilar, Stelara)

Dong-A ST Receives the CHMP’s Positive Opinion for Imuldosa (Biosimilar, Stelara)

October 22, 2024

Dong-A ST Reports the US FDA’s Approval of Imuldosa (Biosimilar, Stelara)

Dong-A ST Reports the US FDA’s Approval of Imuldosa (Biosimilar, Stelara)

October 14, 2024

Dong-A ST Reports P-III Study Results of Ustekinumab Biosimilar DMB-3115 for the Treatment of Chronic Plaque Psoriasis

Dong-A ST Reports P-III Study Results of Ustekinumab Biosimilar DMB-3115 for the Treatment of Chronic Plaque Psoriasis

January 17, 2023

Dong-A ST Signed an Exclusive License Agreement with Polifarma for NESP Biosimilar DA-3880

Dong-A ST Signed an Exclusive License Agreement with Polifarma for NESP Biosimilar DA-3880

November 9, 2022

Insights+ Key Biosimilars Events of July 2021

Insights+ Key Biosimilars Events of July 2021

August 5, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us